CClinicalTrials.gg
WithdrawnNCT06094621Updated Mar 7, 2025

Effect of Pre-operative Virtual Visits on Patients With Head and Neck Cancer Undergoing Surgery

An observational study in Head and Neck Cancer, sponsored by University of Michigan Rogel Cancer Center. Withdrawn. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-03-07.

Sponsored by University of Michigan Rogel Cancer Center · Observational

Why this study was withdrawn
No Investigator Interest
Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
0
Ages
18 Years and older
Sex
All
01

Study summary

Patients with head and neck cancer often undergo complex surgeries requiring significant care post-operatively. This presents considerable psychosocial challenges in addition to their need to physically recover from a large surgery.

The study team will interview patients who have undergone virtual visits before their surgical procedures. The study aims to explore patients' experiences, satisfaction, and perceptions of virtual visits for informing and preparing them for surgery and their postoperative care needs.

The study team will also analyze the effects of the virtual visits on financial costs and patient outcomes such as length of hospital stay, delayed discharges due to social issues, and whether the virtual visits identified any significant medical concerns, etc. The study team will compare these to a randomly selected cohort of patients who also underwent surgical resection and reconstruction for head and neck cancer that did not get pre-operative virtual visits.

02

Conditions studied

  • Head and Neck Cancer
03

In context

Head and Neck Neoplasms

2,344 studies on the registry are indexed under Head and Neck Neoplasms; 551 are open to participants now.

Browse Head and Neck Neoplasms studies →

Lead sponsor

University of Michigan Rogel Cancer Center is the lead sponsor of 316 studies on the registry; 46 are open to participants now.

Of its 46 completed or terminated interventional studies of FDA-regulated products, 30 (65%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Participants will be adult patients aged 18 and over who underwent surgical resection for head and neck cancer with free flap reconstruction at the University of Michigan through the Department of Otolaryngology.

Eligibility criteria

Inclusion Criteria (Pre-operative Visit Arm)

  • Patients > 18 years
  • Underwent surgery for head and neck cancer with free flap reconstruction at the University of Michigan
  • Underwent a pre-operative virtual visit.

Inclusion Criteria (NO Pre-operative Visit Arm)

  • Patients > 18 years
  • Underwent surgery for head and neck cancer with free flap reconstruction at the University of Michigan

Exclusion Criteria (Pre-operative Visit Arm)

  • Patients who died within 60 days of surgery for head and neck cancer with free flap reconstruction at the University of Michigan.

Exclusion Criteria (NO Pre-operative Visit Arm)

  • Patients who died within 60 days of surgery for head and neck cancer with free flap reconstruction at the University of Michigan.
  • Patient underwent a pre-operative virtual visit.
05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
0 participants (actual)
Patient registry
No

Groups and cohorts

  • Pre-operative Visit Arm

    Eligible participants for the interview and surveys will be those who have undergone a virtual visit by the head and neck surgery nurse practitioners before their scheduled surgical procedure.

    Other: Survey

  • No Pre-operative Visit Arm

    Patients who also underwent surgical resection for head and neck cancer with free flap reconstruction at the University of Michigan through the Department of Otolaryngology but did NOT receive a pre-operative virtual visit. This cohort is a retrospective chart review study

Interventions

  • OtherSurvey

    For the patients who underwent a pre-operative virtual visit, data will be collected through semi-structured interviews conducted by trained research personnel. The interviews will be conducted in a one-on-one format, either in-person or via telephone, according to the participant's preference.

06

What researchers measure

Primary outcomes

  1. Effectiveness of virtual visits as determined by satisfaction scores

    To examine the satisfaction scores of patients who undergo pre-operative virtual visits. The satisfaction scale is graded on a modified Likert scale. The endpoint for this primary objective is the score given by the patient on the interview-based survey

    Time frame: at time of enrollment

Secondary outcomes

  1. Comparison in hospitalization between cohorts

    To examine if patients who undergo pre-operative virtual visits have reduced hospital length of stay (i.e. number of days hospitalization post-operatively) compared to patients who did not undergo these visits.

    Time frame: up to 60 days after the surgical resection

  2. Comparison in post-operative communication

    To examine if patients who undergo pre-operative virtual visits have reduced post-operative communication measured in portal messages and phone calls compared to patients who did not undergo these visits.

    Time frame: up to 60 days after the surgical resection

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 7, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06094621
Lead sponsor
University of Michigan Rogel Cancer Center
Responsible party
Sponsor
First posted
Oct 23, 2023
Start date
Mar 2025 (estimated)
Primary completion
Jun 2026 (estimated)
Completion
Jun 2026 (estimated)
Last update
Mar 7, 2025

Study contacts

Keith Casper
principal investigator · University of Michigan

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion